Shots:
Atomwise to receive $20M up front to identify, synthesize, and advance lead compounds for ~5 targets & is eligible to receive ~$1B in research, development, and sales milestones along with royalties that emerge from the collaboration
The collaboration enables Sanofi to use Atomwise’s AtomNet platform for computational discovery and research of ~5 drug targets
Atomwise’s exclusive library of 3+ trillion synthesizable chemicals may be quickly searched using AI by the AtomNet platform which integrates deep learning for structure-based drug creation & accelerating the discovery of new therapies
Ref: Businesswire | Image: Sanofi
